{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:44:46Z","timestamp":1790516686125,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.jim.2012.08.008","type":"journal-article","created":{"date-parts":[[2012,8,18]],"date-time":"2012-08-18T02:15:19Z","timestamp":1345256119000},"page":"60-70","source":"Crossref","is-referenced-by-count":24,"title":["Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells"],"prefix":"10.1016","volume":"385","author":[{"given":"Abu E.","family":"Rasul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mi","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebba","family":"Sohlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nika","family":"\u00c1dori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Erik","family":"Claesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2012.08.008_bb0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2009.04.025","article-title":"Epstein\u2013Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells","volume":"284","author":"Anastasiadou","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jim.2012.08.008_bb0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1074-7613(00)00049-2","article-title":"The expression pattern of Epstein\u2013Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell","volume":"13","author":"Babcock","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.jim.2012.08.008_bb0015","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/jcp.50.11.911","article-title":"Presence of Epstein\u2013Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas","volume":"50","author":"Brink","year":"1997","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jim.2012.08.008_bb0020","first-page":"1858","article-title":"Infection of leukaemic B lymphocytes by Epstein\u2013Barr virus","volume":"7","author":"Doyle","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.jim.2012.08.008_bb0025","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1099\/0022-1317-70-11-2989","article-title":"The role of methylation in the phenotype-dependent modulation of Epstein\u2013barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein\u2013Barr virus","volume":"70","author":"Ernberg","year":"1989","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jim.2012.08.008_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ijc.2910310104","article-title":"Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation","volume":"31","author":"Gerdes","year":"1983","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jim.2012.08.008_bb0035","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1099\/0022-1317-71-7-1481","article-title":"Different Epstein\u2013Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt lymphoma cell line","volume":"71","author":"Gregory","year":"1990","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jim.2012.08.008_bb0040","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1158\/0008-5472.CAN-06-3566","article-title":"Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma","volume":"67","author":"Hjalgrim","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jim.2012.08.008_bb0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-065X.1999.tb01328.x","article-title":"Vaccine strategies against Epstein\u2013Barr virus associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation","volume":"170","author":"Khanna","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jim.2012.08.008_bb0050","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/ijc.20654","article-title":"In vitro EBV-infected sub line of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2","volume":"113","author":"Kis","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jim.2012.08.008_bb0055","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1073\/pnas.0912920107","article-title":"Il-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter","volume":"107","author":"Kis","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jim.2012.08.008_bb0060","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(94)90125-2","article-title":"Epstein\u2013Barr virus strategy in normal and neoplastic B cells","volume":"77","author":"Klein","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.jim.2012.08.008_bb0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/157339510790231842","article-title":"The central role of leukotriene B4 in Epstein\u2013Barr virus activated innate immunity in vitro","volume":"6","author":"Klein","year":"2010","journal-title":"Curr. Immunol. Rev."},{"key":"10.1016\/j.jim.2012.08.008_bb0070","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1073\/pnas.71.8.3283","article-title":"Continuous lymphoid cell lines with characteristics of B Cells (bone-marrow-derived), lacking the Epstein\u2013Barr virus genome and derived from three human lymphomas","volume":"71","author":"Klein","year":"1974","journal-title":"PNAS"},{"key":"10.1016\/j.jim.2012.08.008_bb0075","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/sj.onc.1210240","article-title":"Epstein\u2013Barr virus infection in humans: from harmless to life endangering virus\u2013lymphocyte interactions","volume":"26","author":"Klein","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.jim.2012.08.008_bb0080","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.imlet.2007.12.006","article-title":"Activation of innate immunity by leukotriene B4 inhibits EBV induced B-cell transformation in cord blood derived mononuclear cultures","volume":"116","author":"Klein","year":"2008","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jim.2012.08.008_bb0085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.virol.2007.12.027","article-title":"Interleukin-21 regulates expression of key Epstein\u2013Barr virus oncoproteins, EBNA2 and LMP1, in infected human B cells","volume":"374","author":"Konforte","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.jim.2012.08.008_bb0090","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nri1201","article-title":"B cells under influence: transformation of B cells by Epstein\u2013Barr virus","volume":"3","author":"K\u00fcppers","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jim.2012.08.008_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrc2542","article-title":"The biology of Hodgkin's lymphoma","volume":"9","author":"K\u00fcppers","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jim.2012.08.008_bb0100","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1074-7613(00)00048-0","article-title":"EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency","volume":"13","author":"Kurth","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.jim.2012.08.008_bb0105","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1073\/pnas.2627966100","article-title":"Epstein\u2013Barr virus infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction","volume":"100","author":"Kurth","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.jim.2012.08.008_bb0110","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1128\/JVI.78.4.1657-1664.2004","article-title":"High physiological levels of LMP1 result in phosphorylation of eIF2\u03b1 in Epstein\u2013Barr virus-infected cells","volume":"78","author":"Lam","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2012.08.008_bb0115","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1182\/blood-2007-08-102319","article-title":"Leukotriene B4 activates T cell that inhibit B-cell proliferation in EBV-infected cord blood-derived mononuclear cell cultures","volume":"111","author":"Liu","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jim.2012.08.008_bb0120","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.coi.2010.12.014","article-title":"Immune defence against EBV and EBV-associated disease","volume":"23","author":"Long","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jim.2012.08.008_bb0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JVI.01512-10","article-title":"A new model of Epstein\u2013Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas","volume":"85","author":"Ma","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2012.08.008_bb0130","first-page":"227","article-title":"Epstein\u2013Barr virus can infect B-chronic lymphocytic leukaemia cells but it does not orchestrate the cell cycle regulatory proteins","volume":"4","author":"Maeda","year":"2001","journal-title":"J. Hum. Virol."},{"key":"10.1016\/j.jim.2012.08.008_bb0135","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1073\/pnas.84.13.4567","article-title":"Down-regulation of HLA antigens and of the Epstein\u2013Barr virus-encoded latent membrane protein in Burkitt lymphoma lines","volume":"84","author":"Masucci","year":"1987","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jim.2012.08.008_bb0140","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1073\/pnas.1120587109","article-title":"Soluble factors produced by activated CD4+ T cells modulate EBV latency","volume":"109","author":"Nagy","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jim.2012.08.008_bb0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-9896(199706)182:2<151::AID-PATH824>3.0.CO;2-3","article-title":"Epstein\u2013Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype","volume":"182","author":"Niedobitek","year":"1997","journal-title":"J. Pathol."},{"key":"10.1016\/j.jim.2012.08.008_bb0150","first-page":"923","article-title":"Detection of heterogeneous Epstein\u2013Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders","volume":"147","author":"Oudejans","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jim.2012.08.008_bb0155","first-page":"989","article-title":"Relation between neutralization of Epstein\u2013Barr virus and antibodies to cell membrane antigens induced by the virus","volume":"45","author":"Pearson","year":"1970","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jim.2012.08.008_bb0160","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ijc.2910030619","article-title":"Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus","volume":"3","author":"Pope","year":"1968","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jim.2012.08.008_bb0165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.immunol.15.1.405","article-title":"Human cytotoxic T lymphocyte responses to Eostein\u2013Baar virus infection","volume":"15","author":"Rickinson","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jim.2012.08.008_bb0170","first-page":"347","article-title":"Interaction of Epstein\u2013Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells","volume":"50","author":"Rickinson","year":"1982","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2012.08.008_bb0175","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4161\/onci.1.1.18400","article-title":"Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukaemia clone by in vitro EBV infection","volume":"1","author":"Ros\u00e9n","year":"2012","journal-title":"OncoImmunology"},{"key":"10.1016\/j.jim.2012.08.008_bb0180","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/JVI.66.1.122-131.1992","article-title":"Three pathways of Epstein\u2013Barr virus gene activation from EBNA1-positive latency in B lymphocytes","volume":"66","author":"Rowe","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2012.08.008_bb0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0145-2126(98)00154-4","article-title":"MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation","volume":"23","author":"Stacchini","year":"1999","journal-title":"Leuk. Res."},{"key":"10.1016\/j.jim.2012.08.008_bb0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7326\/0003-4819-118-1-199301010-00009","article-title":"Epstein\u2013Barr virus infections, biology, pathogenesis, and management","volume":"118","author":"Straus","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jim.2012.08.008_bb0195","series-title":"Post-transplant Lymphoproliferative Disorders (PTLD)","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.jim.2012.08.008_bb0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000149129","article-title":"Analysis of the transformation of human lymphocytes by Epstein\u2013Barr virus. II. Abortive response of leukemic cells to the transforming virus","volume":"13","author":"Takada","year":"1980","journal-title":"Intervirology"},{"key":"10.1016\/j.jim.2012.08.008_bb0205","first-page":"125","article-title":"Epstein\u2013Barr virus-infected B-chronic lymphocyte leukemia cells express the virally encoded nuclear proteins but they do not enter the cell cycle","volume":"3","author":"Teramoto","year":"2000","journal-title":"J. Hum. Virol."},{"key":"10.1016\/j.jim.2012.08.008_bb0210","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein\u2013Barr virus: exploiting the immune system","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jim.2012.08.008_bb0215","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nrmicro2015","article-title":"The curious case of the tumor virus: 50years of Burkitt's lymphoma","volume":"6","author":"Thorley-Lawson","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jim.2012.08.008_bb0220","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ijc.2910440517","article-title":"Activation and immortalization of leukaemic B cells by Epstein\u2013Barr virus","volume":"44","author":"Walls","year":"1989","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jim.2012.08.008_bb0225","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ijc.2910350107","article-title":"A re-examination of the Epstein\u2013Barr virus carrier state in healthy seropositive individuals","volume":"35","author":"Yao","year":"1985","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jim.2012.08.008_bb0230","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein\u2013Barr virus: 40years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat. Rev. Cancer"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175912002438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175912002438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T17:41:36Z","timestamp":1594575696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175912002438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":46,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0022175912002438"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2012.08.008","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}